Unusual volume stocks are being observed in Wednesday's session. The trading volume of these stocks is deviating from the norm in today's session.
This Pharma Stock Rose 200% On Monday Morning And Retail Says Valuation Could Rise To $5B: Here’s Why Sara Hurvitz, co-principal investigator for the trial, said that the data for both combination treatments in the trials are “potentially practice-changing.”
Celcuity Stock Skyrockets On Breakthrough Trial Data For Heavily Pretreated Breast Cancer Celcuity shares jump as gedatolisib shows strong efficacy in HR+/HER2- breast cancer Phase 3 trial, with FDA filing expected in late 2025.
CELC Stock Earnings: Celcuity Beats EPS for Q2 2024 CELC stock results show that Celcuity beat analyst estimates for earnings per share the second quarter of 2024.
CELC Stock Earnings: Celcuity Beats EPS for Q1 2024 CELC stock results show that Celcuity beat analyst estimates for earnings per share the first quarter of 2024.
Top movers in Friday's after hours session Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
CELC Stock Earnings: Celcuity Beats EPS for Q4 2023 CELC stock results show that Celcuity beat analyst estimates for earnings per share the fourth quarter of 2023.
